This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected
into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing
loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Collaborator:
National Institute on Deafness and Other Communication Disorders (NIDCD)